Scarica l'app Stockscreener
2.38
6.67%
-0.17
Dopo l'orario di chiusura:
2.40
0.02
+0.84%
Invivyd Inc Borsa (IVVD) Ultime notizie
Aug Gainers: Why Heiwa Real Estate Co Ltd HZJ stock appears on watchlistsDividend Hike & Growth Focused Entry Reports - moha.gov.vn
Invivyd Inc. | Latest News & Innovations - shababeek.org
BTIG initiates Invivyd (IVVD) coverage, cites VYD2311’s superior market potential over Pemgarda - MSN
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda - Insider Monkey
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311's Superior Market Potential Over Pemgarda - Finviz
Invivyd (NASDAQ:IVVD) Trading Down 3.7%Here's Why - MarketBeat
Is Invivyd Inc. stock supported by strong fundamentalsChart Pattern Recognition & Minimal Risk High Reward - bollywoodhelpline.com
Does Invivyd’s (IVVD) Index Debut Reveal a Turning Point in Its Biotech Credibility? - Yahoo Finance
BTIG Reiterates Invivyd (IVVD) Buy Recommendation - Nasdaq
BTIG Research Upgrades Invivyd (NASDAQ:IVVD) to Strong-Buy - MarketBeat
Invivyd granted FDA fast track status for COVID therapy - MSN
FDA grants fast track designation for Invivyd’s COVID antibody By Investing.com - Investing.com Nigeria
Invivyd begins phase 3 trial of COVID prevention antibody VYD2311 By Investing.com - Investing.com Nigeria
US OPEN: Markets wobble amid low volumes and resilient GDP (23.12.2025) - XTB.com
Is Invivyd’s (IVVD) Index Debut Quietly Reframing Its Long-Term Biotech Positioning? - simplywall.st
Invivyd wins FDA fast track tag for COVID drug (IVVD:NASDAQ) - Seeking Alpha
Invivyd Says Vaccine-Alternative Antibody to Prevent COVID Gets FDA Fast Track Designation; Phase 3 Trial Launched - marketscreener.com
Invivyd’s COVID Antibody VYD2311 Receives FDA Fast Track - TipRanks
FDA grants fast track designation for Invivyd’s COVID antibody - Investing.com India
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID - The Manila Times
Invivyd announces initiation of DECLARATION clinical trial, a phase 3 placebo-controlled pivotal study of VYD2311, a vaccine-alternative antibody to prevent Covid-19 - marketscreener.com
Invivyd stock rises after FDA grants Fast Track designation for COVID antibody - Investing.com Canada
Invivyd, Inc. Earns Fast Track Designation for COVID Antibody - TradingView — Track All Markets
Invivyd rises as drugmaker starts late-stage trial for COVID prevention antibody - TradingView — Track All Markets
Invivyd begins phase 3 trial of COVID prevention antibody VYD2311 - Investing.com
FDA puts COVID prevention shot alternative from Invivyd on Fast Track - Stock Titan
New antibody shot aims to offer vaccine-alternative protection from COVID - Stock Titan
Invivyd (IVVD): Assessing Valuation After S&P Biotechnology Select Industry Index Inclusion - Yahoo Finance
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
Invivyd announces proposed public offering of common stock - MSN
Invivyd, Inc. (IVVD): Advancing RSV antibody VBY329 amid analyst downgrade - MSN
Invivyd (NASDAQ:IVVD) Shares Gap UpShould You Buy? - MarketBeat
BTIG Initiates Invivyd at Buy With $10 Price Target - marketscreener.com
Invivyd stock initiated with Buy rating at BTIG on COVID antibody potential - Investing.com India
Invivyd stock initiated with Buy rating at BTIG on COVID antibody potential By Investing.com - Investing.com South Africa
BTIG Initiates Coverage of Invivyd (IVVD) with Buy Recommendation - Nasdaq
Invivyd, Inc.(NasdaqGM: IVVD) added to S&P Biotechnology Select Industry Index - marketscreener.com
Invivyd, Inc.(NasdaqGM: IVVD) added to NASDAQ Biotechnology Index - marketscreener.com
Invivyd, Inc. (NASDAQ:IVVD) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Invivyd Inc (IVVD) Stock News & Articles - 24/7 Wall St.
Aug Sentiment: Is Invivyd Inc. stock undervalued vs historical averagesWeekly Investment Summary & Smart Swing Trading Alerts - Улправда
How Invivyd Inc. stock reacts to Fed rate cutsProduct Launch & Technical Pattern Alert System - ulpravda.ru
Is Invivyd Inc. stock a good choice for value investorsJuly 2025 Gainers & Long Hold Capital Preservation Plans - Улправда
Is Invivyd Inc. stock undervalued vs historical averages2025 Historical Comparison & Fast Entry High Yield Tips - Улправда
How analysts rate Invivyd Inc. stock todayWeekly Stock Report & High Accuracy Investment Signals - DonanımHaber
How Recent Clinical Progress Is Rewriting the Story for Invivyd - Yahoo Finance
What sentiment indicators say about Invivyd Inc. stock2025 Sector Review & Smart Money Movement Tracker - Улправда
Invivyd, Inc. (IVVD): Advancing RSV Antibody VBY329 Amid Analyst Downgrade - Yahoo Finance
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):